138 related articles for article (PubMed ID: 11672942)
1. Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.
Evans SM; Walsh SL; Levin FR; Foltin RW; Fischman MW; Bigelow GE
Drug Alcohol Depend; 2001 Nov; 64(3):271-83. PubMed ID: 11672942
[TBL] [Abstract][Full Text] [Related]
2. Rivastigmine does not alter cocaine-induced subjective effects or self-administration.
Patel M; Verrico CD; De La Garza R
Pharmacol Biochem Behav; 2019 Oct; 185():172758. PubMed ID: 31430484
[TBL] [Abstract][Full Text] [Related]
3. Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans.
Smith BJ; Jones HE; Griffiths RR
Psychopharmacology (Berl); 2001 Aug; 156(4):435-44. PubMed ID: 11498721
[TBL] [Abstract][Full Text] [Related]
4. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.
De La Garza R; Galloway GP; Newton TF; Mendelson J; Haile CN; Dib E; Hawkins RY; Chen CY; Mahoney JJ; Mojsiak J; Lao G; Anderson A; Kahn R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():44-52. PubMed ID: 24316175
[TBL] [Abstract][Full Text] [Related]
5. Effects of labetalol treatment on the physiological and subjective response to smoked cocaine.
Sofuoglu M; Brown S; Babb DA; Pentel PR; Hatsukami DK
Pharmacol Biochem Behav; 2000 Feb; 65(2):255-9. PubMed ID: 10672977
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.
Nann-Vernotica E; Donny EC; Bigelow GE; Walsh SL
Psychopharmacology (Berl); 2001 Jun; 155(4):338-47. PubMed ID: 11441423
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
Comer SD; Mogali S; Saccone PA; Askalsky P; Martinez D; Walker EA; Jones JD; Vosburg SK; Cooper ZD; Roux P; Sullivan MA; Manubay JM; Rubin E; Pines A; Berkower EL; Haney M; Foltin RW
Neuropsychopharmacology; 2013 Nov; 38(12):2427-38. PubMed ID: 23736314
[TBL] [Abstract][Full Text] [Related]
8. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
[TBL] [Abstract][Full Text] [Related]
9. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans.
Sofuoglu M; Singha A; Kosten TR; McCance-Katz FE; Petrakis I; Oliveto A
Pharmacol Biochem Behav; 2003 Jul; 75(4):801-8. PubMed ID: 12957222
[TBL] [Abstract][Full Text] [Related]
10. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.
Foltin RW; Haney M
Pharmacol Biochem Behav; 2004 May; 78(1):93-101. PubMed ID: 15159138
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral cocaine on intravenous cocaine discrimination in humans.
Johanson CE; Lundahl LH; Schubiner H
Exp Clin Psychopharmacol; 2007 Jun; 15(3):219-27. PubMed ID: 17563208
[TBL] [Abstract][Full Text] [Related]
12. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.
Walsh SL; Geter-Douglas B; Strain EC; Bigelow GE
J Pharmacol Exp Ther; 2001 Oct; 299(1):147-58. PubMed ID: 11561074
[TBL] [Abstract][Full Text] [Related]
13. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals.
Grasing K; Mathur D; Newton TF; DeSouza C
Drug Alcohol Depend; 2010 Feb; 107(1):69-75. PubMed ID: 19836169
[TBL] [Abstract][Full Text] [Related]
14. The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.
Pirtle JL; Hickman MD; Boinpelly VC; Surineni K; Thakur HK; Grasing KW
Pharmacol Biochem Behav; 2019 May; 180():52-59. PubMed ID: 30811963
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravenous cocaethylene and cocaine in humans.
Hart CL; Jatlow P; Sevarino KA; McCance-Katz EF
Psychopharmacology (Berl); 2000 Apr; 149(2):153-62. PubMed ID: 10805610
[TBL] [Abstract][Full Text] [Related]
16. Acute cocaine responses following cocaethylene infusion.
Baker J; Jatlow P; Pade P; Ramakrishnan V; McCance-Katz EF
Am J Drug Alcohol Abuse; 2007; 33(4):619-25. PubMed ID: 17668348
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.
De La Garza R; Bubar MJ; Carbone CL; Moeller FG; Newton TF; Anastasio NC; Harper TA; Ware DL; Fuller MA; Holstein GJ; Jayroe JB; Bandak SI; Reiman KZ; Neale AC; Pickford LB; Cunningham KA
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():40-48. PubMed ID: 25602710
[TBL] [Abstract][Full Text] [Related]
18. Smoked cocaine self-administration is decreased by modafinil.
Hart CL; Haney M; Vosburg SK; Rubin E; Foltin RW
Neuropsychopharmacology; 2008 Mar; 33(4):761-8. PubMed ID: 17568397
[TBL] [Abstract][Full Text] [Related]
19. Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans.
Haney M; Collins ED; Ward AS; Foltin RW; Fischman MW
Psychopharmacology (Berl); 1999 Mar; 143(1):102-10. PubMed ID: 10227086
[TBL] [Abstract][Full Text] [Related]
20. Modulation of intravenous cocaine effects by chronic oral cocaine in humans.
Walsh SL; Haberny KA; Bigelow GE
Psychopharmacology (Berl); 2000 Jul; 150(4):361-73. PubMed ID: 10958077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
